A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed

Vaccine

Volumn 30, Issue 32, 2012, Pages 4778-4784

  Pajewski, Nicholas M ^a   Shrestha, Sadeep ^b   Quinn, Conrad P ^c   Parker, Scott D ^d   Wiener, Howard ^b   Aissani, Brahim ^b   McKinney, Brett A ^e   Poland, Gregory A ^f   Edberg, Jeffrey C ^g   Kimberly, Robert P ^g   Tang, Jianming ^d   Kaslow, Richard A ^b,d  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF TULSA   (United States)

^f MAYO CLINIC   (United States)

^g The University of Alabama at Birmingham   (United States)

Author keywords

Anthrax vaccines; Bacillus anthracis; Bacterial vaccines; Genome wide association study; Vaccination

Indexed keywords

ANTHRAX VACCINE; SUPPRESSOR OF CYTOKINE SIGNALING;

ADULT; ANTIBODY RESPONSE; ARTICLE; CHROMOSOME 1P; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOST; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, MHC CLASS II; GENETICS, POPULATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUES; HAPLOTYPES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA-BINDING PROTEINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84862571933     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.05.032     Document Type: Article

References (44)

1. Marano N., Plikaytis B.D., Martin S.W., Rose C., Semenova V.A., Martin S.K., et al. Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial. JAMA 2008, 300(13):1532-1543.
2. BioThrax - Package Insert. ; 2010 [accessed 03.15.10]. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/UCM074923.pdf.
3. Saile E., Quinn C.P. Anthrax vaccines. Bacillus anthracis and anthrax 2010, 269-293. Wiley-Blackwell, New Jersey. N. Bergman (Ed.).
4. Singer D.E., Schneerson R., Bautista C.T., Rubertone M.V., Robbins J.B., Taylor D.N. Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel. Vaccine 2008, 26(7):869-873.
5. Hanson J.F., Taft S.C., Weiss A.A. Neutralizing antibodies and persistence of immunity following anthrax vaccination. Clin Vaccine Immunol 2006, 13(2):208-213.
6. Crowe S.R., Garman L., Engler R.J.M., Farris D., Ballard J.B., Harley J.B., et al. Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity. Vaccine 2011, 29(20):3670-3678.
7. Tan P.L., Jacobson R.M., Poland G.A., Jacobsen S.J., Pankratz V.S. Twin studies of immunogenicity - determining the genetic contribution to vaccine failure. Vaccine 2001, 19(17-19):2434-2439.
8. Pajewski N.M., Parker S.D., Poland G.A., Ovsyannikova I.G., Song W., Zhang K., et al. The role of HLA-DR-DQ haplotypes in variable antibody responses to Anthrax Vaccine Adsorbed. Genes Immun 2011, 12(6):457-465.
9. Fellay J., Frahm N., Shianna K.V., Cirulli E.T., Casimiro D.R., Robertson M.N., et al. Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial. J Infect Dis 2011, 203(6):773-779.
10. Png E., Thalamuthu A., Ong R.T., Snippe H., Boland G.J., Seielstad M. A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet 2011, 20(19):3893-3898.
11. Bienek D.R., Loomis L.J., Biagini R.E. The anthrax vaccine: no new tricks for an old dog. Hum Vaccines 2009, 5(3):184-189.
12. Couzin-Frankel J. Bioterror research. Panel endorses anthrax vaccine study in children. Science 2011, 334(6056):577.
13. Poland G.A., Ovsyannikova I.G., Jacobson R.M. Vaccine immunogenetics: bedside to bench to population. Vaccine 2008, 26(49):6183-6188.
14. Kumar R., Chow C.C., Bartels J.D., Clermont G., Vodovotz Y. A mathematical simulation of the inflammatory response to anthrax infection. Shock 2008, 29(1):104-111.
15. Madigan D. Anthrax vaccines: bridging correlates of protection in animals to immunogenicity in humans. 8 November 2007, Center for Biologics Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services, Washington, DC.
16. Semenova V.A., Schiffer J., Steward-Clark E., Soroka S., Schmidt D.S., Brawner M.M., et al. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG. J Immunol Methods 2012, 376(1-2):97-107.
17. Manichaikul A., Mychaleckyj J.C., Rich S.S., Daly K., Sale M., Chen W.M. Robust relationship inference in genome-wide association studies. Bioinformatics 2010, 26(22):2867-2873.
18. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-575.
19. Cortes A., Brown M.A. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011, 13(1):101.
20. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria. ; 2010. http://www.r-project.org/.
21. Yang J., Benyamin B., McEvoy B.P., Gordon S., Henders A.K., Nyholt D.R., et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010, 42(7):565-569.
22. Lee S.H., Wray N.R., Goddard M.E., Visscher P.M. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 2011, 88(3):294-305.
23. Yang J., Lee S.H., Goddard M.E., Visscher P.M. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011, 88(1):76-82.
24. Dudbridge F., Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 2008, 32(3):227-234.
25. Makowsky R., Pajewski N.M., Klimentidis Y.C., Vazquez A.I., Duarte C.W., Allison D.B., et al. Beyond missing heritability: prediction of complex traits. PLoS Genet 2011, 7:e1002051.
26. Hindorff LA, MacArthur J, Wise A, Junkins H, Hall P, Klemm A, et al. A catalog of published genome-wide association studies. Available at [accessed 01.15.10]. http://www.genome.gov/gwastudies.
27. Guzmán B., Cormand B., Ribasés M., González-Núñez D., Botey A., Poch E. Implication of chromosome 18 in hypertension by sibling pair and association analyses: putative involvement of the RKHD2 gene. Hypertension 2006, 48(5):883-891.
28. Bucasas K.L., Franco L.M., Shaw C.A., Bray M.S., Wells J.M., Niño D., et al. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis 2011, 203(7):921-929.
29. Nakaya H.I., Wrammert J., Lee E.K., Racioppi L., Marie-Kunze S., Haining W.N., et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011, 12(8):786-795.
30. Wang D., Li Z., Messing E.M., Wu G. The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway. J Biol Chem 2005, 280(16):16393-16401.
31. Nishiya T., Matsumoto K., Maekawa S., Kajita E., Horinouchi T., Fujimuro M., et al. Regulation of inducible nitric-oxide synthase by the SPRY domain- and SOCS box-containing proteins. J Biol Chem 2011, 286(11):9009-9019.
32. Lewis R.S., Kolesnik T.B., Kuang Z., D'Cruz A.A., Blewitt M.E., Masters S.L., et al. TLR regulation of SPSB1 controls inducible nitric oxide synthase induction. J Immunol 2011, 187(7):3798-3805.
33. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753.
34. Eichler E.E., Flint J., Gibson G., Kong A., Leal S.M., Moore J.H., et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010, 11(6):446-450.
35. Farrall M. Quantitative genetic variation: a post-modern view. Hum Mol Genet 2004, 13(Spec No. 1):R1-R7.
36. Hill W.G. Understanding and using quantitative genetic variation. Philos Trans R Soc Lond B: Biol Sci 2010, 365(1537):73-85.
37. Hill W.G., Goddard M.E. PLoS Genet 2008, 4(2):e1000008.
38. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460(7256):748-752.
39. Lango Allen H., Estrada K., Lettre G., Berndt S.I., Weedon M.N., Rivadeneira F., et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010, 467(7317):832-838.
40. Speliotes E.K., Willer C.J., Berndt S.I., Monda K.L., Thorleifsson G., Jackson A.U., et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010, 42(11):937-948.
41. Teslovich T.M., Musunuru K., Smith A.V., Edmondson A.C., Stylianou I.M., Koseki M., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466(7307):707-713.
42. Meuwissen T.H. Accuracy of breeding values of unrelated individuals predicted by dense SNP genotyping. Genet Sel Evol 2009, 41:35.
43. Nakaya H.I., Pulendran B. Systems vaccinology: its promise and challenge for HIV vaccine development. Curr Opin HIV AIDS 2012, 7:24-31.
44. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449(7164):851-861.